BioCentury
ARTICLE | Regulation

FDA's financial disclosure plan

September 26, 1994 7:00 AM UTC

WASHINGTON - The FDA has published proposed conflict-of-interest rules mandating financial disclosures by clinical investIgators.

The proposed regulations require that the sponsor of any drug, biological product, or device submit information concerning the compensation to, and financial interests of, any investigator conducting clinical studies to support a marketing application to the agency. ...